Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS‐CoV‐2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics

References

• Amin, S. A., Banerjee, S., Ghosh, K., Gayen, S., & Jha, T. (2021). Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors. Bioorganic & Medicinal Chemistry, 29, 115860. https://doi.org/10.1016/J.BMC.2020.115860.
   PubMedGoogle Scholar
• Amin, S. A., Banerjee, S., Singh, S., Qureshi, I. A., Gayen, S., & Jha, T. (2021). First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery. Molecular Diversity, 25(3), 1827–1838.
   PubMed Web of Science ®Google Scholar
• Brooke, G. N., & Prischi, F. (2020). Structural and functional modelling of SARS-CoV-2 entry in animal models. Science Reports, 101(10), 1–11. https://doi.org/10.1038/s41598-020-72528-z
   Google Scholar
• Congreve, M., & Murray, C. W., Blundell, T. L. (2005). Structural biology and drug discovery. Drug Discovery Today, 10, 895–907. https://doi.org/10.1016/S1359-6446(05)03484-7
   PubMed Web of Science ®Google Scholar
• Chen, C., Han, D., Cai, C., & Tang, X. (2010). An overview of liposome lyophilization and its future potential. Journal of Controlled Release: Official Journal of the Controlled Release Society, 142(3), 299–311. https://doi.org/10.1016/j.jconrel.2009.10.024.
   PubMed Web of Science ®Google Scholar
• Choudhary, M. I., Shaikh, M., tul-Wahab, Atia., & ur-Rahman, A. (2020). In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. PLoS One. 15(7), e0235030. https://doi.org/10.1371/journal.pone.0235030
   PubMed Web of Science ®Google Scholar
• Elbadwi, F. A., Khairy, E. A., Alsamani, F. O., Mahadi, M. A., Abdalrahman, S. E., Ahmed, Z. A. M., Elsayed, I., Ibraheem, W., & Alzain, A. A. (2021). Identification of novel transmembrane protease serine type 2 drug candidates for COVID-19 using computational studies. Informatics in Medicine Unlocked, 26, 100725. https://doi.org/10.1016/j.imu.2021.100725.
   PubMedGoogle Scholar
• Elfiky, A. A., Mahdy, S. M., & Elshemey, W. M. (2017). Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses. Journal of Medical Virology, 89(6), 1040–1047. https://doi.org/10.1002/jmv.24736.
   PubMed Web of Science ®Google Scholar
• Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. Journal of Biomolecular Structure and Dynamics., 39(9), 1–7. https://doi.org/10.1080/07391102.2020.1760136/SUPPL_FILE/TBSD_A_1760136_SM3437.PDF
   Google Scholar
• Farouk, A., Hassan, M., Imran, M., Park, T., Alotaibi, S. S., & Dong, J. (2021). Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism : A viroinformatics study. Saudi Journal of Biological Sciences, 28(6), 3262–3269. Saudi J. Biol. Sci. https://doi.org/10.1016/j.sjbs.2021.02.066.
   PubMed Web of Science ®Google Scholar
• From SARS to, H. R. (2014). MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS Journal 281, 4085–4096. https://doi.org/10.1111/FEBS.12936
   PubMed Web of Science ®Google Scholar
• Jiménez-Avalos, G., Vargas-Ruiz, A. P., Delgado-Pease, N. E., Olivos-Ramirez, G. E., Sheen, P., Fernández-Díaz, M., Quiliano, M., Zimic, M., A., Agurto-Arteaga, R., Antiparra, M., Ardiles-Reyes, K., Calderon, Y., Cauna-Orocollo, M., de Grecia Cauti-Mendoza, N., Chipana-Flores, R., Choque-Guevara, X., Chunga-Girón, M., Criollo-Orozco, L., De La Cruz, A., Poma-Acevedo, … Quiñones-Garcia, I. (2021). Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO, Science Reports 11 1–19. https://doi.org/10.1038/s41598-021-94951-6
   Google Scholar
• Gajjar, N. D., Dhameliya, T. M., & Shah, G. B. (2021). In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis. Journal of Molecular Structure, 1239, 130488. https://doi.org/10.1016/j.molstruc.2021.130488.
   PubMed Web of Science ®Google Scholar
• Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2021). Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors–an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure & Dynamics, 39(12), 4362–4374. https://doi.org/10.1080/07391102.2020.1779818
   PubMed Web of Science ®Google Scholar
• Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., Niemeyer, D., Schneider, H., Drosten, C., & Pöhlmann, S. (2011). Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of Virology, 85(9), 4122–4134. https://doi.org/10.1128/JVI.02232-10.
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell. 181, 271–280.https://doi.org/10.1016/j.cell.2020.02.052.
   PubMed Web of Science ®Google Scholar
• Hu, X., Shrimp, J. H., Guo, H., Xu, M., Chen, C. Z., Zhu, W., Zakharov, A., Jain, S., Shinn, P., Simeonov, A., Hall, M. D., & Shen, M. (2020). Discovery of TMPRSS2 inhibitors from virtual screening. BioRxiv, https://doi.org/10.1101/2020.12.28.424413
   Google Scholar
• Hu, X., Shrimp, J. H., Guo, H., Xu, M., Chen, C. Z., Zhu, W., Zakharov, A. V., Jain, S., Shinn, P., Simeonov, A., Hall, M. D., & Shen, M. (2021). Discovery of TMPRSS2 inhibitors from virtual screening as a potential treatment of COVID-19. ACS Pharmacology & Translational Science, 4(3), 1124–1135. https://doi.org/10.1021/acsptsci.0c00221.
   PubMedGoogle Scholar
• Hussain, M., Jabeen, N., Amanullah, A., Baig, A. A., Aziz, B., Shabbir, S., Raza, F., & Uddin, N. (2020). Molecular docking between human tmprss2 and sars-cov-2 spike protein: Conformation and intermolecular interactions. AIMS Microbiology, 6(3), 350–360. https://doi.org/10.3934/microbiol.2020021.
   PubMed Web of Science ®Google Scholar
• Ibrahim, I. M., Abdelmalek, D. H., Elshahat, M. E., & Elfiky, A. A. (2020). COVID-19 spike-host cell receptor GRP78 binding site prediction. The Journal of Infection, 80(5), 554–562. https://doi.org/10.1016/J.JINF.2020.02.026.
   PubMed Web of Science ®Google Scholar
• Idris, M. O., Yekeen, A. A., Alakanse, O. S., & Durojaye, O. A. (2020). Computer-aided screening for potential TMPRSS2 inhibitors: A combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches., 5638-5656. https://doi.org/10.1080/07391102.2020.1792346.
   Google Scholar
• Idris, M. O., Yekeen, A. A., Alakanse, O. S., & Durojaye, O. A. (2021). Computer-aided screening for potential TMPRSS2 inhibitors: A combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics. 39(15), 5638-5656. https://doi.org/10.1080/07391102.2020.1792346
   Google Scholar
• Jain, V., & Yuan, J.-M. (2020). Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: A systematic review and meta-analysis. International Journal of Public Health, 65(5), 533–546. https://doi.org/10.1007/s00038-020-01390-7.
   PubMed Web of Science ®Google Scholar
• Jayaweera, M., Perera, H., Gunawardana, B., & Manatunge, J. (2020). Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environmental Research, 188, 109819. https://doi.org/10.1016/j.envres.2020.109819.
   PubMed Web of Science ®Google Scholar
• Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., Rollin, P. E., Dowell, S. F., Ling, A.-E., Humphrey, C. D., Shieh, W.-J., Guarner, J., Paddock, C. D., Rota, P., Fields, B., … Anderson, L. J, SARS Working Group. (2003). A novel coronavirus associated with severe acute respiratory syndrome. The New England Journal of Medicine, 348(20), 1953–1966. https://doi.org/10.1056/nejmoa030781.
   PubMed Web of Science ®Google Scholar
• Li, K., Meyerholz, D. K., Bartlett, J. A., & McCray, P. B. (2021). The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19. MBio, 12(4), e00970-21. https://doi.org/10.1128/mBio.00970-21
   Google Scholar
• Liang, J., Karagiannis, C., Pitsillou, E., Darmawan, K. K., Ng, K., Hung, A., & Karagiannis, T. C. (2020). Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface. Computational Biology and Chemistry, 89, 107372. https://doi.org/10.1016/j.compbiolchem.2020.107372.
   PubMed Web of Science ®Google Scholar
• Lokhande, K. B., Doiphode, S., Vyas, R., & Swamy, K. V. (2021). Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19. Journal of Biomolecular Structure and Dynamics. 39, 1–12. https://doi.org/10.1080/07391102.2020.1805019
   PubMed Web of Science ®Google Scholar
• Masters, P. S. (2006). The molecular biology of Coronaviruses. Adv. Virus Res, 65, 193–292. https://doi.org/10.1016/S0065-3527(06)66005-3
   Web of Science ®Google Scholar
• Naik, B., & Venkata Satish Kumar, M., Nidhi, G., Ojha, R., Pundarikaksha, D., Satyendra, S., Prajapati, V. K., & Prusty, D. (2021). Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2021.1931451
   Google Scholar
• Nagarajan, H., Lakshmi, P. D., & Vetrivel, U. (2020). Deciphering potential inhibitors targeting THI4 of Fusarium solani sp. to combat fungal keratitis : An integrative computational approach. Computational Biology and Chemistry, 88, 107350. https://doi.org/10.1016/j.compbiolchem.2020.107350.
   PubMed Web of Science ®Google Scholar
• Noureddine, O., Issaoui, N., & Al-Dossary, O. (2021). DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19. Journal of King Saud University. Science, 33(1), 101248. https://doi.org/10.1016/j.jksus.2020.101248.
   PubMed Web of Science ®Google Scholar
• Peacock, T. P., Goldhill, D. H., Zhou, J., Baillon, L., Frise, R., Swann, O. C., Kugathasan, R., Penn, R., Brown, J. C., Sanchez-David, R. Y., Braga, L., Williamson, M. K., Hassard, J. A., Staller, E., Hanley, B., Osborn, M., Giacca, M., Davidson, A. D., Matthews, D. A., & Barclay, W. S. (2020). The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells. BioRxiv, 2020.09.30.318311. https://doi.org/10.1101/2020.09.30.318311
   Google Scholar
• Prajapat, M., Shekhar, N., Sarma, P., Avti, P., Singh, S., Kaur, H., Bhattacharyya, A., Kumar, S., Sharma, S., Prakash, A., & Medhi, B. (2020). Journal of Molecular Graphics and Modelling Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS. Journal of Molecular Graphics & Modelling, 101, 107716. https://doi.org/10.1016/j.jmgm.2020.107716.
   PubMed Web of Science ®Google Scholar
• Prashantha, C. N., Gouthami, K., Lavanya, L., Bhavanam, S., Jakhar, A., Shakthiraju, R. G., Suraj, V., Sahana, K. V., Sujana, H. S., Guruprasad, N. M., & Ramachandra, R. (2021). Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. Journal of Molecular Graphics & Modelling, 102, 107769. https://doi.org/10.1016/j.jmgm.2020.107769.
   PubMed Web of Science ®Google Scholar
• Quimque, M. T. J., Notarte, K. I. R., Fernandez, R. A. T., Mendoza, M. A. O., Liman, R. A. D., Lim, J. A. K., Pilapil, L. A. E., Ong, J. K. H., Pastrana, A. M., Khan, A., Wei, D. Q., & Macabeo, A. P. G. (2020). Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics. 1102, 4316-4333. https://doi.org/10.1080/07391102.2020.1776639
   Google Scholar
• Rasool, N., Yasmin, F., Sahai, S., Hussain, W., Inam, H., & Arshad, A. (2021). Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2 : Molecular docking, DFT and MD simulation investigations. Chemical Physics Letters, 771, 138463. https://doi.org/10.1016/j.cplett.2021.138463.
   PubMed Web of Science ®Google Scholar
• Shulla, A., Heald-Sargent, T., Subramanya, G., Jincun, Z., Perlman, S., & Gallagher, T. (2011). A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of Virology, 85, 873–882. https://doi.org/10.1128/JVI.02062-10.
   PubMed Web of Science ®Google Scholar
• Sarma, P., Shekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2021). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure & Dynamics, 39(8), 2724–2732. https://doi.org/10.1080/07391102.2020.1753580.
   PubMed Web of Science ®Google Scholar
• Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020). Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America, 117(21), 11727–11734. https://doi.org/10.1073/PNAS.2003138117.
   PubMed Web of Science ®Google Scholar
• Sobhia, M. E., Ghosh, K., Sivangula, S., Kumar, S., & Singh, H. (2022). Identification of potential SARS-CoV-2 Mpro inhibitors integrating molecular docking and water thermodynamics. Journal of Biomolecular Structure and Dynamics 40(11), 1–11. https://doi.org/10.1080/07391102.2020.1867642
   PubMed Web of Science ®Google Scholar
• Tyrrell, D. A. J., Almeida, J. D., Cunningham, C. H., Dowdle, W. R., Hofstad, M. S., McIntosh, K., Tajima, M., Zakstelskaya, L. Y., Easterday, B. C., Kapikian, A., & Bingham, R. W. (1975). Coronaviridae. Intervirology, 5(1/2), 76–82. https://doi.org/10.1159/000149883.
   PubMed Web of Science ®Google Scholar
• Ullrich, S., & Nitsche, C. (2020). The SARS-CoV-2 main protease as drug target. Bioorganic & Medicinal Chemistry Letters, 30(17), 127377. https://doi.org/10.1016/j.bmcl.2020.127377.
   PubMed Web of Science ®Google Scholar
• Usha, T., Shanmugarajan, D., Goyal, A. K., Kumar, C. S., & Middha, S. K. (2017). Recent updates on computer-aided drug discovery: Time for a paradigm shift. Current Topics in Medicinal Chemistry, 17(30), 3296–3307. https://doi.org/10.2174/1568026618666180101163651.
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd, H., & Gifford, E. (2003). ADMET in silico modelling: Towards prediction paradise? Nature Reviews. Drug Discovery, 2(3), 192–204. 2https://doi.org/10.1038/nrd1032.
   PubMed Web of Science ®Google Scholar
• Vardhan, S., & Sahoo, S. K. (2022). Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. Journal of Traditional Complementary Medicine, 12(1), 6–15. https://doi.org/10.1016/j.jtcme.2021.04.001
   PubMedGoogle Scholar
• WHO Coronavirus. (2021) Dashboard|WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/
   Google Scholar
• WHO, Coronavirus disease (COVID-19). (2020). https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=EAIaIQobChMI2eb5i7eN8QIVuRkGAB2I1AAuEAAYASAAEgI5T_D_BwE
   Google Scholar
• Wruck, W., & Adjaye, J. (2020). SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress, Sci. Reports 10 1–14. https://doi.org/10.1038/s41598-020-78402-2.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/10.1126/SCIENCE.ABB3405.
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., Si, H. R., Zhu, Y., Li, B., Huang, C. L., Chen, H. D., Chen, J., Luo, Y., Guo, H., Jiang, R. D., Liu, M. Q., Chen, Y., Shen, X. R., Wang, X., … Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar